In addition, mutations in the mTOR gene itself, which is a downstream target of PI3K/AKT, sustain the mTOR signaling pathway in a hyper-activated state, and regulate the growth and metabolism of tumor cells [28]. The gene discussed is AKT1; the disease is neoplasm.